TORONTO, ON--(Marketwired - August 29, 2016) - During a live broadcast on Wednesday, September 21, 2016, a panel of experts including Elizabeth (Nicki) Bush, Research Scientist at Eli Lilly and Company, Rachel Ballinger, Lead Outcomes Researcher at ICON, and Helen Doll, Senior Principal, Clinical Outcomes Assessments at ICON, will present conceptual and logistical challenges of both qualitative and quantitative studies to assess the content validity and measurement properties of these PerfO assessments in these patient groups, and the results from these studies.
As a type of Clinical Outcome Assessment (COA), Performance Outcome assessments (PerfOs) specifically refer to task(s) performed by a patient according to instructions administered by a health care professional. They thus require patient cooperation and motivation (FDA, COA Glossary of terms). While PerfO assessments such as walk and stair climbing tests are widely used to assess the effectiveness of interventions, and there is some evidence on the measurement properties of the tests, there is no regulatory guidance in terms of assessment development and validation specific to PerfOs. While the Patient Reported Outcome guidance (FDA/SEALD Guidance for Industry 2009) provides a useful framework, PerfOs do present specific challenges.
This webinar will draw on experience in validating a select group of PerfO assessments in orthopaedics, an area with a strong history of performance measurement, with the intention of supporting future labelling claims. The PerfO assessments were Timed Up and Go, Stair Climbs and Repeated Chair Stands which were administered in hip fracture and elective hip and elective knee replacement patients in a multi-site study.
The speakers will also reflect on the value of FDA Guidance on the use of PRO measures (FDA/SEALD Guidance for Industry 2009) for PerfOs, and review the FDA Clinical Outcome Assessment Compendium and other sources for indication of the extent and nature of use of PerfOs to support labelling claims in conditions more widely.
The objectives of this webinar are to:
- Briefly describe PerfOs and related terminology
- Describe how PerfO assessments compare with other COAs and the breadth of PerfOs
- Provide an in-depth orthopedic case study
- Highlight practical and logistical issues of assessing select physical PerfO assessments
- Demonstrate the approach taken to validating selected PerfO assessments
- Share validation study results
- Provide clear take-away messages to help inform approach to selecting and validating PerfO assessments for physical mobility-type conditions
- Provide an indication as to the extent and nature of PerfOs used to support labelling claims more widely
To learn more about this complimentary event visit: Validating Select Physical Performance Outcome (PerfO) Assessments to Support Labelling Claims in the US: Methods and Lessons Learned
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx
Image Available: http://www.marketwire.com/library/MwGo/2016/8/26/11G111929/Images/ICON_logo_200-830120556669.jpg